NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1427410810 MD
Verify on CMS → Lindsay Hunter, MD
Medical Oncology Physician in Salt Lake City, Utah.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
394
Medicare Part D claims · 85 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.9/100
▼ 9 pts below national avg 83.1 · Mid-tier
Industry payments
$149.38
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Lindsay Hunter, MD reported a CMS MIPS final score of 73.9/100 - below the 83.1 national average - and filed 394 Medicare Part D claims in 2023.
- 73.9/100
- MIPS score · -9 vs avg
- 394
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Lindsay Hunter, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
74 11th percentile higher than 11% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lindsay Hunter, MD sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lindsay Hunter, MD writes more Part D claims than 42% of them and scores higher on MIPS quality than 5% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Lindsay Hunter, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Lindsay Hunter, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lindsay Hunter, MD?
Below national averagePrimary specialty
Medical Oncology Physician
Medicare Part D claims
394 43% vs specialty avg
MIPS final score
73.9/100 9.2 pts vs avg
Specialty distribution in Utah
How Medical Oncology Physician compares to other specialties among Utah providers
Medicare quality performance, MIPS
Lindsay Hunter, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 73.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 73.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Lindsay Hunter, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 5131 S COTTONWOOD ST # L2, Salt Lake City, UT, 84107, with a listed phone of (801) 263-3416. NPI 1427410810 was issued on 03/24/2016.
Medicare Part D records for calendar year 2023 show 394 prescription claims written by this provider, covering 85 Medicare beneficiaries and totaling roughly $425K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 10.2%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.9/100 for the 2023 performance year (Quality 61, Cost 50.3), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1427410810 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/24/2016 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
73.9058
Final Score
Avg: 83.1
61.008
Quality
50.3317
Cost
91
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Lindsay Hunter, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Utah Cancer Specialists PC
Murray, UT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lindsay Hunter, MD. Source: openpaymentsdata.cms.gov.
Total received
$149
Largest payer
BeiGene USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Lindsay Hunter, MD - brand share 14.0%
Medical Oncology Physician average
14% brand-name claims vs 86% generic, on 394 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
394
Total Claims
$425K
Total Drug Cost
85
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 560
- Total Day Supply
- 12,710
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $415K
- Generic Drug Cost
- $9K
- Opioid Claims
- 40 (10.2% rate)
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 73.7 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lindsay Hunter, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
44 claims
- Ondansetron Hcl
Ondansetron Hcl
41 claims
- Prochlorperazine M…
Prochlorperazine Maleate
38 claims
- Oxycodone Hcl
Oxycodone Hcl
24 claims
- Tamoxifen Citrate
Tamoxifen Citrate
23 claims
- Hydroxyurea
Hydroxyurea
18 claims
- Sodium Chloride 14
Sodium Chloride
14 claims
- Letrozole 13
Letrozole
13 claims
| Drug | Claims |
|---|---|
| Anastrozole | 44 |
| Ondansetron Hcl | 41 |
| Prochlorperazine Maleate | 38 |
| Oxycodone Hcl | 24 |
| Tamoxifen Citrate | 23 |
| Hydroxyurea | 18 |
| Sodium Chloride 0.9 % Sodium Chloride | 14 |
| Letrozole | 13 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Lindsay Hunter, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Lindsay Hunter, MD's 394 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in Utah
Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as Hunter.
Dr. Wallace Akerley
MD
Salt Lake City, UT
Dr. Khaled Alhamad
MD
Salt Lake City, UT
Dr. Saundra Buys
MD
Salt Lake City, UT
Dr. Sarah Colonna
MD
Salt Lake City, UT
Dr. Ignacio Garrido-Laguna
MD
Salt Lake City, UT
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Utah medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Utah
Frequently Asked Questions
What is Lindsay Hunter, MD's specialty? ▼
Lindsay Hunter, MD specializes in Medical Oncology Physician and practices in Salt Lake City, Utah. Credentials: MD.
How much does Lindsay Hunter, MD prescribe under Medicare Part D? ▼
In 2023, Lindsay Hunter, MD wrote 394 Medicare Part D claims totaling $425K in drug costs for 85 beneficiaries.
What is Lindsay Hunter, MD's Medicare quality score? ▼
Lindsay Hunter, MD has a CMS MIPS Final Score of 73.9/100 (Quality: 61, Cost: 50.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lindsay Hunter, MD located? ▼
Lindsay Hunter, MD is located at 5131 S COTTONWOOD ST # L2, Salt Lake City, UT, 84107. Phone: (801) 263-3416.
What is Lindsay Hunter, MD's NPI number? ▼
Lindsay Hunter, MD's National Provider Identifier (NPI) is 1427410810, issued on 03/24/2016.
Does Lindsay Hunter, MD prescribe more brand-name or generic drugs? ▼
Lindsay Hunter, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $415K in brand drug costs.
Does Lindsay Hunter, MD prescribe opioids? ▼
Yes, Lindsay Hunter, MD had 40 opioid claims in 2023 with an opioid prescribing rate of 10.2%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Lindsay Hunter, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Lindsay Hunter, MD's most frequently prescribed drugs include Anastrozole, Ondansetron Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lindsay Hunter, MD accept Medicare? ▼
Lindsay Hunter, MD appears in CMS Medicare data with 394 Part D claims and 85 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lindsay Hunter, MD's credentials? ▼
Lindsay Hunter, MD's NPI is 1427410810 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.